People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| 2seventy bio, Inc. | — | Biotechnology | Series D+ | $170.0M | $4.0B | 2022 |
Daniel D. Lynch at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel D. Lynch on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nick Leschly | 1 | 5 |
| William R. Sellers | 1 | 2 |
| Denice R. Torres | 1 | 2 |
| William D. Baird | 1 | 2 |
| Ramy R. Ibrahim | 1 | 1 |
| Nicola Heffron | 1 | 1 |
| Marcela V. Maus | 1 | 1 |
| Philip D. Gregory | 1 | 1 |
| Sarah JS Glickman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.